Dr. Zanos recently presented our laboratory’s groundbreaking findings at the Mediterranean Neuroscience Society conference held in Tunis (https://www.medneuroscisociety.org/mns2023_info). His presentation focused on the novel discoveries surrounding the paradigm-shifting mechanisms responsible for the rapid-antidepressant efficacy of ketamine and other potential compounds currently in clinical phase development.

This presentation highlights the significant contributions of our laboratory to the field of neuroscience and reinforces our commitment to advancing the understanding of rapid-acting antidepressant treatments. We are proud of Dr. Zanos’ dedication and the team’s exceptional work in this important area of research.

Stay tuned for more updates on our latest research and achievements.